NCPA 2025 Recap: Ownership, AI, and Surviving the MFP Cash Crunch
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
NCPA 2025 Recap: Ownership, AI, and Surviving the MFP Cash Crunch
-
Narrado por:
-
De:
Send us a text
Schedule an Rx Assessment
Subscribe to Master The Margin
How will the Medicare Drug Price Negotiation Program reshape independent pharmacy? What should owners be doing now to prepare?
In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, and Austin Murray sit down in the new studio to recap NCPA 2025 from an ownership, cash flow, and strategy lens.
We cover:
- A 50,000-foot view of the Medicare Drug Price Negotiation Program
- Key trends among startup vs. acquisition-minded owners
- Pharmacy business plans and clinical services
Stay connected with us on social media:
Facebook
More on this topic:
Podcast: The Trusted Pharmacist: Advocacy and Building a Resilient Pharmacy
Podcast: From Counter to Capitol